Total revenues of $665.9 million ($664.2 million on an adjusted basis) compared to $582.2 million ($577.4 million on an adjusted basis) in the prior year quarterNet income of $22.7 million ($31.5 ...
Materials science is an interdisciplinary field concerned with the understanding and application of the properties of matter. Materials scientists study the connections between the underlying ...
On January 14, 2025, the Board approved a one-for-two-hundred (1:200) Reverse Split of the Common Stock. The Company anticipates that beginning with the opening of trading on February 10, 2025, the ...
Keith Buettner; Vice President, IR and Financial Planning and Analysis; Xylem Inc. Matthew Pine; President, Chief Executive Officer, Director; Xylem Inc. William Gro ...
Ben Krasinski; Director, Investor Relations; Premier Inc. Michael Alkire; President, Chief Executive Officer, Director; Premier Inc. Glenn Coleman; Chief Financial O ...
Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, leading with tecarfarin, a new Vitamin K antagonist will ...
Good day, and welcome to the Mondelez International Fourth Quarter 2024 and Full Year Earnings Conference Call. Today's call is scheduled to last about one hour, including remarks by Mondelez ...